Hayward, CA, United States of America

Scott Siler

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Siler - Innovator in Diabetes Modeling

Introduction

Scott Siler is an accomplished inventor based in Hayward, California. He has made significant contributions to the field of diabetes research through his innovative patent. His work focuses on the complex physiological mechanisms involved in diabetes and related disorders.

Latest Patents

Scott Siler holds a patent for a "Method and apparatus for computer modeling diabetes." This invention relates to a mathematical and computer model that addresses diabetes-related disorders, particularly human type 2 diabetes. The model encompasses various macronutrient metabolism processes, including fat, protein, and carbohydrate metabolism. It effectively simulates the interconversion of macronutrients and their digestion, absorption, storage, mobilization, and adaptive utilization. Additionally, the model accounts for the endocrine control of these processes and can predict the effects of therapeutic interventions on a heterogeneous group of diabetes-related disorders.

Career Highlights

Scott Siler is associated with Entelos, Inc., where he applies his expertise in diabetes modeling. His innovative approach has the potential to enhance the understanding of diabetes and improve treatment strategies. He has been instrumental in developing tools that can simulate various diabetes-related conditions, providing valuable insights for researchers and healthcare professionals.

Collaborations

Scott has collaborated with notable colleagues, including Paul Brazhnik and Kevin Hall. Their combined efforts contribute to advancing research in diabetes and related fields.

Conclusion

Scott Siler's work in diabetes modeling represents a significant advancement in understanding and treating diabetes-related disorders. His innovative patent and collaboration with esteemed colleagues highlight his commitment to improving health outcomes for individuals affected by diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…